SCHEMBL370179

SCHEMBL370179

C[C@@H](OS(=O)(=O)c1ccc([N+](=O)[O-])cc1)C(N)=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.49
F2 P00734 3/20 0.48
PRSS1 P07477 3/20 0.48
PRSS2 P07478 3/20 0.48
PRSS3 P35030 3/20 0.48
CA1 P00915 6/20 0.46
CA2 P00918 6/20 0.46
CA12 O43570 5/20 0.46
CA9 Q16790 5/20 0.46
CA14 Q9ULX7 5/20 0.46
CA3 P07451 3/20 0.46
CA4 P22748 3/20 0.46
CA6 P23280 3/20 0.46
CA5A P35218 3/20 0.46
CA7 P43166 3/20 0.46
CA13 Q8N1Q1 3/20 0.46
CA5B Q9Y2D0 3/20 0.46
ALDH1A1 P00352 2/20 0.46
HSP90AA1 P07900 1/20 0.46
KMT2A Q03164 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL370180 1.00 POLB (0.49) POLBF2PRSS1PRSS2PRSS3
SCHEMBL4371962 0.86 MMP9 (0.50) POLBCA1CA2CA12CA9
SCHEMBL10867412 0.86 MMP9 (0.50) POLBCA1CA2CA12CA9
SCHEMBL15630892 0.84 POLB (0.51) POLBF2PRSS1PRSS2PRSS3
SCHEMBL10615659 0.84 POLB (0.51) POLBF2PRSS1PRSS2PRSS3
SCHEMBL15631944 0.84 POLB (0.51) POLBF2PRSS1PRSS2PRSS3
SCHEMBL10012970 0.82 ALDH1A1 (0.46) POLBF2PRSS1PRSS2PRSS3
SCHEMBL19469361 0.82 CA2 (0.52) POLBF2PRSS1PRSS2PRSS3
SCHEMBL8874363 0.81 RAB9A (0.49) POLBALDH1A1HSP90AA1KMT2AMAPT
SCHEMBL8874371 0.81 RAB9A (0.49) POLBALDH1A1HSP90AA1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8835685-B2 Process for the preparation of contrast agents BRACCO IMAGING S.P.A. (IT) 2014-09-16 US claimed
EP-2593423-B1 PROCESS FOR THE PREPARATION OF CONTRAST AGENTS BRACCO IMAGING SPA (IT) 2014-09-03 EP claimed
US-20130131382-A1 Process For The Preparation Of Contrast Agents BRACCO IMAGING S.P.A. (IT) 2013-05-23 US claimed
EP-2593423-A1 PROCESS FOR THE PREPARATION OF CONTRAST AGENTS Bracco Imaging S.p.A (IT) 2013-05-22 EP claimed
WO-2012007547-A1 PROCESS FOR THE PREPARATION OF CONTRAST AGENTS BRACCO IMAGING S.P.A. (IT) 2012-01-19 WO claimed
US-8835685-B2 Process for the preparation of contrast agents BRACCO IMAGING S.P.A. (IT) 2014-09-16 US disclosed
EP-2593423-B1 PROCESS FOR THE PREPARATION OF CONTRAST AGENTS BRACCO IMAGING SPA (IT) 2014-09-03 EP disclosed
US-20130131382-A1 Process For The Preparation Of Contrast Agents BRACCO IMAGING S.P.A. (IT) 2013-05-23 US disclosed
EP-2593423-A1 PROCESS FOR THE PREPARATION OF CONTRAST AGENTS Bracco Imaging S.p.A (IT) 2013-05-22 EP disclosed
WO-2012007547-A1 PROCESS FOR THE PREPARATION OF CONTRAST AGENTS BRACCO IMAGING S.P.A. (IT) 2012-01-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130131382-A1 Process For The Preparation Of Contrast Agents SLC1A5, SLC30A5, SLC9B2 POLB 1367/4885F2 2719/4885PRSS1 4010/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.